PREPARED BY: DR.MOHAMMED H. ALKHAISHANI OTHER MODALITIES IN THE TREATMENT OF EPILEPSY.

Slides:



Advertisements
Similar presentations
E Feoli MD North East Regional Epilepsy Group 2012
Advertisements

Avoidance A small minority of patients do have seizures following well defined stimuli. This is known as reflex epilepsy. If seizure triggers can be identified.
Martha J. Morrell MD NeuroPace, Inc.
Northeast Regional Epilepsy Group Christos Lambrakis M.D. 1.
What to do IF Medications Fail? Dr Linda Huh Pediatric Neurologist BCCH.
Stereotactic Radiosurgery Jimmy Johannes Physics 335 – Spring 2004 Final Presentation
EPILEPSY D. C. MIKULECKY PROFESSOR OF PHYSIOLOGY.
Transcranial Magnetic Stimulation
Drug Resistant Epilepsy: Diagnostic and Treatment Options Mark A. Granner, MD Medical Director, Epilepsy Monitoring Unit Co-Director, Iowa Comprehensive.
Video-EEG Monitoring in Childhood Epilepsy
Epilepsy Madyson Longtin 3/6/13 Psych honoros Period 3.
PSYC4080 Seizure Disorders 1. PSYC4080 Seizure Disorders 2  Abnormal electrical discharge in the brain.  Neurons firing together in synchrony: paroxysmal.
Epilepsy surgery.
Diagnosis and Treatment of Epilepsy Marcelo E. Lancman, M.D. Director, Epilepsy Program NEREG.
Surgery Surgery is the initial therapy for nearly all patients with brain tumors and can cure most benign tumors, including meningiomas Goal : to remove.
Deep Brain Stimulation Mark Anil Mansingh Simon Putzenlechner Philipp Bartner.
Neoadjuvant Adjuvant Curative Palliative Neoadjuvant Radiation therapy the results of a phase III study from Beijing demonstrated a survival benefit.
Deep Brain Stimulation For parkinson’s disease
Spinal Cord Stimulators in Neuropathic Pain. Introduction Chronic pain is very common Immense physical, psychological, societal impact Financial burden.
Overview of Neurostimulation
 ALL will understand biological explanations and treatments for OCD  MOST will be able to explain biological explanations and treatments for OCD  SOME.
Seizure disorders are treated primarily with antiseizure drugs. Therapy is aimed at preventing seizures because cure is not possible. Drugs generally.
Epilepsy: Insights into Consciousness. Obligatory Historical Quote: “Men ought to know that from the brain, and from the brain only, arise our pleasures,
Neurological Disorders Lesson 4.6 What causes epilepsy?
1 Overview of Gamma Knife ® Surgery Dr. Sandra Vermeulen, M.D. Swedish Cancer Institute Northwest Hospital Gamma Knife Center Seattle, Washington Learn.
 Identify different options of cancer therapy.  Most cancers are treated with a combination of approaches.
Epilepsy Lecture Neuro Course 4th year. Objectives – To Review: What the term epilepsy means Basic mechanisms of epilepsy How seizures and epilepsies.
U.S. Neurostimulation Markets Leveraging CRM Technology for Treating Neurological Conditions “Until recently, the only modes of treatment for many neurological.
Brain Abscess & Intracranial Tumors
Gaetha Mills, RN, CNRN.  4 bed monitoring unit (with 4 additional beds being constructed)  5 epilepsy fellowship trained Epileptologists  An epilepsy.
Abstract Cerebral cavernous malformations (CCM) are lesions found in the brain and spinal cord comprised of abnormal blood cells, which bleed sporadically.
Responsive Neurostimulation (RNS) for the treatment of epilepsy
Advanced Interventional Options for Chronic Pain October 9, 2105 Daniel Kwon, MD.
American Epilepsy Society
Epilepsy: Insights into Consciousness. Obligatory Historical Quote: “Men ought to know that from the brain… madness comes from its moistness. When the.
The GOLIATH Study ..
Recall the neuronal circuitry change in PD Normal Parkinson’s.
ANTERIOR VENOUS MALFORMATION (BRAIN)
It is essential to obtain the exact history of the hypersalivation as well as a thorough and complete past medical history. Oral evaluation should be performed,
THE IMPLEMENTATION OF ABLATIVE HYPOFRACTIONATED RADIOTHERAPY FOR STEREOTACTIC TREATMENTS IN THE BRAIN AND BODY: OBSERVATIONS ON EFFICACY AND TOXICITY IN.
The Emergence of Therapeutic Neurostimulation: Reducing Barriers to Innovation and Growth John Reppas MD- PhD Director of Public Policy American Society.
Date of download: 6/23/2016 Copyright © 2016 McGraw-Hill Education. All rights reserved. Supplementary Sensorimotor Area (SSMA) Seizure; Subdural vs Scalp.
Imaging of Epilepsy Ali Jassim Alhashli Year IV – Unit VIII (CNS) – Problem 6.
CNS Depressants: Sedative- Hypnotics Chapter 6. Introduction to CNS Depressants Why are CNS depressants problematic? -Usually prescribed under physician’s.
The NeuroPace RNS® System and Surgical Options
Clinical Procedures and Test
Quantification of Dose with Neuromodulation Device
How To Design a Clinical Trial
These slides highlight a presentation at the Late Breaking Trial Session of the American College of Cardiology 52nd Annual Scientific Sessions in Chicago,
Extending intracranial treatment options with Leksell Gamma Knife® Icon™ Key Statements from Customer Perspective by University Medical Centre Mannheim.
CONVULSION & EPILEPSY Dr. Kifah Alubaidy.
The efficiency of neuropathic pain removing using different methods of neurostimulation N.A. Sapon Restorative Neurosurgery Department, Romodanov Neurosurgery.
Mahmoud Taha MD KFSH-Dammam, KSA
Jeopardy! Begin.
The extent of the PET hypometabolism may be substantially larger than the electrical focus.55 The relationship between the area of hypometabolism and the.
Intraoperative Electrocorticography in Temporal Lobe Epilepsy Surgery
Parkinson’s disease.
Male Organ Function and Spinal Cord Injury: 3 Types of Problems
Epilepsy in Diagnostic Imaging
A Proven Non-Drug Treatment for Depression
Management of Patients with Epilepsy
Neurostimulation for the Management of Medication-Resistant Epilepsy
Chapter 2 Biopsychology.
Northeast Regional Epilepsy Group Christos Lambrakis M.D.
Neoadjuvant Adjuvant Curative Palliative
Supported in part by Arkansas Blue Cross and Blue Shield
Susannah J. Tye, PhD, Mark A. Frye, MD, Kendall H. Lee, MD, PhD 
CNS Depressants: Sedative-Hypnotics Chapter 6
D. C. MIKULECKY PROFESSOR OF PHYSIOLOGY
Presentation transcript:

PREPARED BY: DR.MOHAMMED H. ALKHAISHANI OTHER MODALITIES IN THE TREATMENT OF EPILEPSY

ELECTRICAL NEUROMODULATIONS These approaches for extratemporal lobe epilepsy,if despite resection of epileptogenic foci,epilepsy persists or in the palliative circumstance where no seizure focus is demonsrated using scalp recording.

Trigeminal nerve stimulation -Has recently been reported. -In one study on 12 patients,they have 66% seizure frequency reduction at 3 months follow up -Side effects include;orbicularis occuli twitching and dental discomfort and paresthesia. -Still under big trials for it’s superiority over vagus nerve stimulation

Vagus Nerve Stimulation (VNS) -Has been approaved in many countries for; 1- Partial seizures with or without secondary generalization in children older than 12 year 2-Generlaized epilepsy as an adjunct therapy to resective surgical procedures (when they are insufficient ) in children younger than 12 years 3-Patients who is not candidate for surgical resection as tuberous sclerosis complex 4-Patients who refused surgical resection surgical resection when typically indicated achieves higher rates of seizure control.

VNS Trials show differences in seizure frequency reduction between % with high frequency, and 6-15 % with high frequency stimulation. -In one study on 454 patients,median seizure reductions were 44% from base line after 3 years. With 43% of patients having at least 50% seizure frequency reduction, and 20% have persisting hoarseness of voice at 2 years of follow up.

HISTORICAL BACK GROUND -Experiments first shows that intermittent VNS reduced or eliminated interictal epileptic events that were chemically induced in the frontal cortex of cats. In 1987,a company cyberonics was founded to develop VNS therapy in humans. In 1988 the first pt. to undergo implantation of a VNS device became seizure free. Since that time,more than 46,000 neurocybernetic prosthesis(NCP)has been implanted to treat epilepsy worldwide.-

Mechanism -The NCP delivers intermittent afferent electrical stimulation to the left cervical vagus nerve trunk, wich secondarily transmits impulses that exert widespread effects on neuronal excitability throughout the CNC.

COMPLICATIONS -Infection. -Vocal cord paralysis. -Brady cardia\asystol -Malfunctioning -Sleep-related breathing disorders ****Future is promising

DEEP BRAIN STIMULATION FOR EPILEPSY(DPS) -Although palliative,DBS has the advantage of tissue preservation and also the potential ability to influence multifocal epilepsy. -Generlaized tonic-clonic seizures appeared to show the best response.

Indications a-In temporal lobe epilepsy ; for bilateral mesial temporal sclerosis,if one is dominent in epilepsy firing(for the non-dominant one after surgical resection of the dominant side) b-For extratemporal epilepsy ; 1-if epilepsy persists despite resection of the epileptogenic foci. 2-if no epilepsy focus is demonstrated using scalp recording.

Surgical Approaches for Epilepsy 1-Resective surgery -Temporal lobe resections: “standard,” - amygd.hiamygdalohippocampectomy (SAH) -Extratemporal resections -Lesional resections -Anatomic hemispherectomy 2-Disconnection surgery -Corpus callosotomy -Keyhole hemispherotomies -Multiple subpial transection (MST) 4-Neuroaugmentive surgery -Vagal nerve stimulation (VNS) -Deep brain stimulation (DBS) 5-Radiosurgery

Radiation Therapy of Epilepsy -Stereotactic radiosurgery(SRS) developed to treat functional disorders such as pain and movement disorders. -The earliest widespread uses of SRS focused on deep-seated tumors or AVM located in eloquent regions of the brain, using it as a means of treating these lesions while avoiding the risks associated with surgical resection. - -With in these contexts, seizures were treated as secondary manifestations of the primary disorder, rather than as specific conditions. -Subsequent to radiosurgical treatment, significant reduction, or even resolution, of the associated seizures has been documented.

MODERN INDICATIONS 1-Hypothalamic hamartomas 2-Mesial temporal lobe epilepsy : that associated With mesial temporal sclerosis 3-Secondary epilepsies: to tumors and AVM 4-Non-lesional epilepsies: especially SRS or corp. callosotomy

GAMMA SURGERY FOR EPILEPSY -The interest in using gamma surgery for epilepsy was triggered by an early report that seizures were alleviated in aseries of (AVM)case. -In 59 of the 247 patients with seizure as the presenting symptom,treated using gamma knife surgery between 1970 and 1984,the treatment resulted in ;relief of some or all seizures in 52 of these patients,11 were successfully taken off anticonvulsant medication, and in 3 patients seizure disorder symptoms were eleminated,although the AVM itself was un affected by the radiation.

LOCAL EFFECT -Biochemical analysis of changes after gamma surgery (in non human models),showed changes in the concentrations of excitatory and inhibitory aminoacids, particularly GABA. -One study shows that,patients with low grade astro- cytomas and assosiated epilepsy had significant relief from seizures following interstitial radiosurgery. SPECT scanning showed a reduced number of GABA receptors prior to treatment in both the tumors and sorrounding brain. Levels of these receptors increased following therapy. -These studies show that functional changes may occur at the cellular level without gross structural damage.

LONG TERM OUTCOME -Not promising because non of those patients is seizure-free after 138 months of follow up(unknown mechanisim). -The safety and short- term efficacy of gamma surgery for the treatment of epilepsies arising from space occupying lesions (e.g. low grade gliomas, hypothalamic hamartomas, cavernous malformations,and arteriovenous malformations) Make it an attractive option. -The gamma knife’s long-term feasibility and effectiveness for MTLE need to be proved.

Why there is amelioration of seizures following radio-surgery -The mechanism is exactly unknown -Some have suggested a “neuromodulation” phenomenon following gamma surgery With accompanying glial cell reduction,stem cell migration,neuronal plasticity and sprouting, and biochemical changes(rigorous scientific studies are far lacking)T

CONCLUSION -The indications and usefulness of gamma surgery for functional disorders are being defined more carefully with the passage of time -The advances of neuroimaging in the last several decades have offered the identification of discrete thalamic, subthalamic, and basal ganglia nuclei with acceptable confidence. -The ongoing developments of non-invasive physiologic monitoring will influence the development of gamma surgery for epilepsy. -When every thing is considerd,one may contend that while gamma surgery may be used for functional diseases of the brain,the current efficacy of alternative methods significantly limits the role of gamma surgery in the management of these diseases.

THANK YOU